Transcriptome and proteome analyses of adaptive responses to methyl methanesulfonate in Escherichia coli K-12 and ada mutant strains
© Baek et al; licensee BioMed Central Ltd. 2009
Received: 17 February 2009
Accepted: 3 September 2009
Published: 3 September 2009
The Ada-dependent adaptive response system in Escherichia coli is important for increasing resistance to alkylation damage. However, the global transcriptional and translational changes during this response have not been reported. Here we present time-dependent global gene and protein expression profiles following treatment with methyl methanesulfonate (MMS) in E. coli W3110 and its ada mutant strains.
Transcriptome profiling showed that 1138 and 2177 genes were differentially expressed in response to MMS treatment in the wild-type and mutant strains, respectively. A total of 81 protein spots representing 76 nonredundant proteins differentially expressed were identified using 2-DE and LC-MS/MS. In the wild-type strain, many genes were differentially expressed upon long-exposure to MMS, due to both adaptive responses and stationary phase responses. In the ada mutant strain, the genes involved in DNA replication, recombination, modification and repair were up-regulated 0.5 h after MMS treatment, indicating its connection to the SOS and other DNA repair systems. Interestingly, expression of the genes involved in flagellar biosynthesis, chemotaxis, and two-component regulatory systems related to drug or antibiotic resistance, was found to be controlled by Ada.
These results show in detail the regulatory components and pathways controlling adaptive response and how the related genes including the Ada regulon are expressed with this response.
Alkylation damage to DNA occurs when cells encounter alkylating agents in the environment or when active alkylators are generated by nitrosation of amino acids in metabolic pathways [1, 2]. The DNA damage by alkylating agents results in disruption of DNA function and cell death. The alkylating agents represent an abundant class of chemical DNA damaging agent in our environment and are toxic, mutagenic, teratogenic and carcinogenic. Since we are continuously exposed to alkylating agents, and since certain alkylating agents are used for cancer chemotherapy, it is important to understand exactly how cells respond to these agents. Alkylating agents are commonly used anti-cancer drugs and remain important for the treatment of several types of cancer [3, 4]. Alkylating drugs are mostly methylating agents (e.g. temozolomide and streptozotocin, an antibiotic) or chloroethylating agents (e.g. carmustine, lomustine and fotemustine) . The efficacies of these drugs are strongly modulated by DNA repair process. Thus, thorough understanding and controlling of the repair processes will allow development of new therapies by protecting normal tissues or by potentiating effects in the target tissues.
To cope with DNA alkylation damage, cells have evolved genes that encode proteins with alkylation-specific DNA repair activities. It is notable that these repair systems are conserved from bacteria to humans . In Escherichia coli, cells exposed to a low concentration of an alkylating agent, such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or methyl methanesulfonate (MMS), show a remarkable increase in resistance to both the lethal and mutagenic effects of subsequent high-level challenge treatments with the same or other alkylating agents [7, 8]. This increased resistance has been known as "adaptive response" to alkylation damage in DNA.
To date, four genes have been identified as components of this response, ada, alk A, alk B and aid B. The ada gene encodes the Ada protein, which has the dual function of a transcriptional regulator for the genes involved in the adaptive response, and a methyltransferase that demethylates two methylated bases (O6meG and O4meT) and methylphosphotriesters produced by methylating agents in the sugar phosphate backbone [6, 9]. When methylated at Cys-69, Ada is converted to a potent activator for the transcription of the ada and alk A, alk B and aid B genes by binding to a consensus sequence referred to as an "Ada box" present in the promoter. The alk A gene encodes a glycosylase that repairs several different methylated bases, and the alk B gene, which forms a small operon with the ada gene, is required for error-free replication of methylated single-stranded DNA . The aid B gene encodes the protein that appears to detoxify nitrosoguanines and to reduce the level of methylation by alkylating agents. Early studies have shown that the expression of the ada-alk B operon, alk A and aid B genes is positively controlled by Ada protein, after it interacts with methylated DNA [11–14]. In contrast, Ada protein also plays a pivotal role in the negative modulation of its own synthesis, and consequently, in the down-regulation of the adaptive response. The carboxyl-terminus of Ada protein appears to be necessary for this negative regulatory function; thus, Ada protein can act as both a positive and a negative regulator for the adaptive response of E. coli to alkylating agents . The transcriptional activity of E. coli Ada protein is also directly regulated by posttranslational covalent modification; however, the regulatory components and pathways controlling the adaptive response have not been well studied.
Recent advances in functional genomics studies have facilitated understanding of global metabolic and regulatory alterations caused by genotypic and/or environmental changes. DNA microarray has proven to be a successful tool for monitoring genome-wide expression profiles at the mRNA level. Similarly, proteomics can be used to compare changes in levels of many proteins under particular genetic and environmental conditions. Furthermore, proteomic studies provide information on posttranslational modifications, which cannot be obtained from mRNA expression profiles; these have proven critical to our understanding of proper physiological protein function, translocation, and subcellular localization. Ideally, information obtained from these technologies needs to be integrated to better understand the phenotypic characteristics of the cell under a given condition . Recently, combined transcriptome and proteome approaches have allowed large-scale analysis of biological systems at the mRNA and protein levels, providing us with a wealth of information that is useful in data-driven discovery [16–19].
In this paper, we report the global expression changes in the gene and protein levels of E. coli K-12 W3110 and ada mutant strains in response to alkylating agents. In addition, the differences between the wild-type and mutant strains without treatment of alkylating agents were characterized at transcriptome and proteome levels. The analysis of time- and strain-dependent adaptive responses revealed the regulatory and physiological characteristics of the Ada-dependent adaptive response in E. coli.
Results and discussion
Growth profiles of E. coli W3110 and ada mutant strains under MMS-treated and -untreated conditions
Transcriptome and proteome profiles of E. coli W3110 in response to MMS
Transcriptome and proteome analyses were performed for the samples taken at 0.5, 1.5 and 3.9 h following MMS treatment for both MMS-treated and -untreated control cultures, and the expression levels were compared. Those genes and proteins which were differentially expressed by greater than 2-fold or less than a half in MMS-treated cells compared with the controls (MMS-untreated cells) were considered to be meaningfully up- or down-regulated ones by MMS treatment.
As expected, 13 genes involved in DNA replication, repair and modification (ada, alk B, din D, mut S, pol B, rec N, rne, sbm C, tpr, tus, umu D and uvr AB) were up-regulated to allow prevention and repair of replication-blocking lesions in E. coli cells exposed to alkylation stress. Among these, the genes in the Ada regulon, ada and alk B were strongly induced, which indicates that cells experiencing DNA damage in response to MMS exposure try to mend the damage by inducing the DNA repair system that is regulated by Ada. In addition to the Ada transcriptional regulator (ada), the expression of the genes encoding other transcriptional regulators, such as the ara C, kdp E, mar A, yad W, yaf C, ybd O and ykg D genes, was significantly up-regulated as seen in the 0.5 h transcriptome profiles. These regulators might influence a dynamic network of the adaptive response. The transcriptome experiments also revealed that genes related to a variety of other cell processes, including chaperones (hsc A and htp G), degradation of small molecules (cai BDT), and adaptation and protection (bet A, gef, htg A, ibp A and mar A), were induced after MMS treatment. These responses are consistent with the proteome data showing the induction of four proteins (AhpF, HtpG, NfnB and YfiD) categorized into the adaptation and protection function. Induction of these proteins seems to be involved in the protection of genes and/or proteins against MMS toxicity.
In addition, a large number of genes with altered expression levels (356 up-regulated and 149 down-regulated) was seen in 3.9 h profiles for E. coli W3110 cells (Figure 2). These mainly included genes involved in structure, cell process and transport. These larger changes in the expression level might be due to the complicated response in the stationary phase to alkylating agents. Previously, Sedgwick et al.  reported that the Ada regulon could be induced during stationary phase and could protect against active alkylators produced by nitrosation of amino acids in non-growing cells. Therefore, an increase in expression of the adaptive response genes, in parallel with expression of the genes producing active alkylators during the stationary phase prevents alkylation damage to DNA and subsequent mutagenesis.
Transcriptome and proteome profiles of the ada mutant strain in response to MMS
Proteome analysis showed variations in the production levels of 21 protein spots; the spot intensities of 18 proteins increased while 3 proteins decreased (Figure 3, Additional file 1: Table S1). Consistent with the transcriptome data, the intensities of proteins involved in metabolism and transport were increased. Proteins that showed significantly increased spot intensities in MMS-treated ada mutant cells at 0.5 h included enzymes for DNA replication, recombination, modification and repair (RecA and Mfd); cell process including adaptation and protection (AhpF, CheA, HtpG and NfnB); translation and posttranslational modification (RpsB, ThrS and an isoform of Tsf); transport and binding proteins (DppA and OppA); metabolisms (FabG, GlpA, PflB, PyrG (spot no. 42) and TreC), and YeaG. Similar to proteome profiles of MMS-treated wild-type cells, one isoform of elongation factor Ts (Tsf) was detected on 2-D gels of MMS-treated ada cells. Interestingly, the MMS treatment of the ada mutant cells resulted in the significant repression of the FliC involved in flagellar biosynthesis, which is consistent with down-regulated expression of this gene in transcriptome data (Additional file 1: Table S1).
In general, E. coli responds to alkylation stress by activating sets of co-regulated genes that help the cell to maintain homeostasis. However, the ada mutant cells would require a more rapid increase in the expression levels of specific genes for DNA repair in response to methylating agents, due to the lack of the Ada-dependent response mechanism. It can be seen from the 0.5 h profiles that the adaptive response mediates the induction of 23 genes involved in DNA replication, recombination, modification and repair, such as b1360, din D, lar, mod F, mut H, ogt, phr B, pin O, pol B, pri A, rec ANT, rnb, rnp A, ruv B, tpr, umu CD, uvr A, yee S, yfb L and yfj Y. MMS treatment also caused a strong induction of the drug or antibiotic resistance genes, most of which are located in cell membrane (Figure 4, Additional file 2). Proteome profiles also showed that RcsB was increased in MMS-treated ada mutant cells. Taken together, the profiles for the ada mutant strain defective in adaptive response showed a far more rapid transcriptional response following MMS treatment when compared to the wild-type. From these results, we reasoned that the responses observed at earlier time point might allow identification of direct targets of the adaptive response, while the long-exposure time profiles would reflect more complex regulation in cellular networks, including both stationary phase responses by the rpo S gene product [23, 24] and adaptive response by alkylating agents. Thus, the transcriptional and translational profiles of the wild-type and the ada mutant strain at 0.5 h were analyzed in more detail.
Differences in expression levels between wild-type and ada mutant strains under normal growth condition
In order to examine the intracellular changes that are induced by the ada gene deletion in the MMS-untreated, normal growth condition, the expression levels of genes and proteins of ada mutant cells were first compared with those of wild-type cells at the mid-log growth phase (at 0.5 h sampling point). The number of genes differentially expressed at greater than 2-fold levels was small. Only 69 and 10 genes were up- and down-regulated, respectively, in the ada mutant strain compared to the wild-type strain (Additional file 2). Interestingly, the expression levels of the genes involved in flagellar biosynthesis (flg CEG and fli AC) and chemotaxis (tar and che W) were higher in the ada mutant strain than in the wild-type. Proteome analysis indicated 26 protein spots that were clearly affected in the ada mutant cells, half of them being significantly over-produced compared with the wild-type strain, while the others being under-produced (Additional file 1: Table S1). Eight proteins, including CheAY, FliC, GlnA, InfB, Mfd, OsmY and PyrG (spot no. 42), were present only in the ada mutant strain, while AnsB, GrcA (two spots), OppA and PyrG (spot no. 4) were detected only in the wild-type strain. Interestingly, the ada mutant cell showed a different isoform distribution for CTP synthase (PyrG) compared with that of the wild-type. This finding suggests that the ada mutation alters this protein by posttranslational modification.
Consistent with the transcriptome data, the main differences between the two strains were identified as the flagellar biosynthesis protein (FliC) and chemotaxis proteins (CheAY). These results indicate that Ada might be a negative regulator of bacterial chemotaxis under normal growth condition. In addition, the small differences between the strains suggest the limited role that Ada plays under normal growth condition. In fact, there have been no reports on any other functions of Ada except its adaptive response to protect cells from DNA damage by alkylating agents . However, our study indicates that Ada plays an additional role as a transcriptional regulator under normal growth condition and this can be a reason why the final concentration of the ada mutant strain was lower than that of the wild-type strain, as shown in Figure 1.
Expression levels of the genes in the Ada regulon
The expression profiles of genes involved in the adaptive response of E. coli could be divided into two groups: namely, ada-like or alk A-like expression profiles. The ada-like expressed genes including the ada, alk B and aid B genes showed the highest expression levels relatively early after MMS addition (at 0.5 h and 1.5 h profiles) and decreased later. On the other hand, the alk A-like expressed genes, such as the alk A gene, presented a gradually increased expression level over the time. A previous study showed that the ada and alk A genes are regulated by a distinct mechanism in response to alkylation damage , and this is supported by our data. However, the differences in the expression levels of the four genes (ada, alk A, alk B and aid B) between the wild-type and ada mutant strains were negligible under normal condition (data not shown), which suggests that this adaptive response might reflect an inducible mechanism that generates genetic variability in times of alkylation stress.
Increased expression levels of the genes and proteins involved in flagellar biosynthesis and chemotaxis
The synthesis and proper functioning of the flagellar and chemotaxis system require the expression of more than 50 genes, which are divided among at least 17 operons constituting the large, coordinately regulated flagellar regulon . As described above, even under normal growth condition, the expression levels of the genes belonging to this group were increased in the ada mutant strain compared to the wild-type strain, and were further increased at 0.5 h following MMS treatment. The key master regulator, encoded by flh CD, was moderately increased in the ada mutant cells at 0.5 h after MMS treatment and five additional flagellar biosynthesis genes (flg AH, flh B and fli ST) were also up-regulated. Four genes involved in the chemotaxis signal transduction system were up-regulated including the genes for three chemoreceptors (aer, tar and trg) and the CheA kinase (che A), which activates the CheY response regulator via phosphorylation and then influences flagellum activity through interaction with the motor. These findings also agree with proteomic data that showed that enzymes of chemotaxis (CheAY) and flagellar biosynthesis (FliC) were detected only in the ada mutant strain (Figure 3, Additional file 1: Table S1). These chemotaxis genes are not directly regulated by FlhDC, but are controlled by the flagellum sigma factor, σF, encoded by fli A. However, the expression of fli A was not significantly changed with time in the ada mutant cells, although the fli AYZ operon is regulated by FlhCD. The protein kinase, CheA, plays a central role in the initial excitation responses to stimuli as well as in the subsequent events associated with adaptation. The activity of the CheA kinase is increased by the increased levels of receptor methylation . High levels of receptor methylation have been correlated with tumbly behavior, providing evidence that changes in receptor methylation mediate adaptive responses to attractant and repellent stimuli. Thus, the increased expression of these genes is closely related to negative Ada-dependent regulation in E. coli and Ada might negatively affect the protein components of bacterial chemotaxis. The flagellar biosynthesis genes and chemotaxis genes seem to contribute to protecting the viability of ada mutant cells by transferring methyl group to methyl-accepting proteins (MCP) such as Aer, Tar and Trg.
Increased expression levels of the genes and proteins related to drugs or antibiotics resistance
The ada mutant cells that are hypersensitive to alkylating agents compared to wild-type cells might need to activate the expression of drug or antibiotic resistance genes to reduce their susceptibility to alkylation damage. In fact, many genes involved in these functions were found to be induced, some rapidly and some later in response to MMS treatment (Figure 4). The expression level of the fsr gene responsible for fosmidomycin resistance was rapidly and continuously induced in both strains after MMS treatment, and this gene also showed increased expression in the ada mutant strain compared to the wild-type under normal growth condition. Additionally, genes encoding the multiple antibiotic resistance protein (mar ABR), microcin B17 uptake protein (sbm A), and putative resistance protein (yde A) were also up-regulated in both strains at 3.9 h post MMS treatment, in the stationary phase. This observation is consistent with the fact that the Ada regulon is highly induced during the stationary phase  and that it protects cells from active alkylators produced by nitrosation of amino acids [1, 2]. However, some of genes belonging to this function showed different expression patterns between the strains. For example, the genes encoding multidrug resistance proteins (emr ABDE) were rapidly induced at 0.5 h profile in the ada mutant strain and decreased afterwards. On the other hand, some of these genes (emr BEY) were increased later at 3.9 h profile only in the wild-type strain. This result suggests that the ada mutant strain might require a timely and rapid induction of the drug or antibiotic resistance genes to reduce its susceptibility to alkylation damage. Proteome data also showed induction of proteins related to detoxification (AhpF and NfnB) in both strains following MMS treatment. Alkylating agents that target DNA-associated processes are anticipated to be far more specific and effective as antibiotics or drugs [3–5]. This seems to be why the drug or antibiotics resistance genes were expressed upon MMS treatment. In addition, it has been demonstrated that DNA repair is enhanced in drug-resistant cell lines and tumors . These results indicate that the expression of drug or antibiotic resistance genes might be affected in the DNA repair processes.
In addition, proteome analysis indicated that RcsB responded to peptidoglycan damage and contributed to intrinsic antibiotic resistance of E. coli  was synthesized at high level in the ada mutant strain. The finding allowed us to further examine the changes of the expression levels of drug or antibiotic resistance genes from transcriptome profiles. Hirakawa et al.  demonstrated that overexpression of fifteen genes, bae R, cit B, cpx R, evg A, fim Z, kdp E, nar LP, omp R, rcs B, rst A, tor R, yed W, yeh T and dcu R, which are response regulators of two-component signal transduction systems in E. coli, conferred increased single- or multidrug resistance. Interestingly, as shown in Figure 4, most of these genes, including the bae R, cit B, cpx R, evg A, fim Z, omp R, rcs B, rst A and yed W genes, were up-regulated in the ada mutant strain at 0.5 h after MMS treatment. Expression of the cognate sensor gene of two-component transduction systems (bae RS, cit AB, cpx AR, evg AS and rst AB, but not yed VW) increased coordinately when it was cotranscribed with the regulator. Increased expression levels were also observed when the sensor was even in a separate operon (fim Z-amp C and omp R-env Z). However, no induction of these two-component transduction genes was observed in MMS-treated wild-type strain. These findings show that the up-regulated genes of the bacterial two-component signal transduction systems might confer MMS resistance in the absence of the ada gene, through the control of the expression of drug or antibiotic transporter genes [29, 30]. This type of response regulator-mediated drug resistance might be required for acquiring MMS toxicity resistance although the mechanism of the response is not yet clear. Furthermore, this is closely correlated with the finding that increased expression levels of the genes involved in transport systems are seen in the 0.5 h profile of the ada mutant strain (Figure 4). The influx and efflux of solutes through the cell might also play a major role in intrinsic tolerance of bacteria to drugs and toxic compounds as adaptive responses.
Induction of DNA repair mechanisms
The prevention of the mutagenic and lethal consequences of DNA damage requires the timely expression of DNA repair and protective genes, in order to maintain the integrity of the genome and viability of the cell. As pointed out before, Ada is an important transcriptional regulator in addition to having a direct role as a methyl acceptor during DNA repair. Thus, the up-regulated expression of the ada gene positively affects cell adaptation of alkylation damage by MMS in E. coli W3110 strain. The high level of ada expression, together with high level of 3-methyladenine-DNA glycosylase (encoded by the alk A gene), might be sufficient to repair these lesions, making high-level expression of the aid B and alk B genes unnecessary at 0.5 h after MMS treatment. This coordinated expression of the alk A and ada genes is noteworthy in that the two gene products repair different types of alkylation damage by different mechanisms, as illustrated . The linked regulation of these two proteins thus optimizes the repair of several diverse lesions that are likely to be formed in DNA by a single alkylating agent. However, it can be postulated that ada mutant strain express higher amounts of other genes involved in DNA repair systems, as well as two different 3-methyladenine-DNA glycosylases (tag and alk A) in order to compensate for its function. Recent studies have demonstrated the presence of a second DNA repair methyltransferase, encoded by the ogt gene, for the direct repair of alkylating lesions in E. coli, in which the ada gene has been inactivated by mutation . This was consistent with our observation that the expression of the ogt gene was highly up-regulated at 0.5 h in the MMS-treated ada mutant cells, showing that the ogt gene is required for cell adaptation in the absence of the ada gene. In addition, the expression of the alk B gene continually increased in MMS-treated ada mutant strain, revealing that these genes can trigger the adaptive response to alkylating agents in the ada mutant strain.
Another reaction that operates by the direct reversal of damage in the DNA of the ada mutant strain at 0.5 h is that of the DNA photolyase, encoded by the phr B gene . Other up-regulated genes and proteins involved in DNA repair  at 0.5 h in the ada mutant strain are endonuclease III and VIII (nth); exonulease III (xth A); endonuclease IV (nfo); mismatch repair (vsr and mut HL); cleaning of precursor pool (mut T); nucleotide excision repair (uvr ABCD, and mfd); and post-replication repair, SOS regulation and translesion synthesis (rec A, lex A and umu DC). Moreover, redox control of transcription (sox RS) and DNA ligase (lig) were moderately increased at 0.5 h in the ada mutant strain. Proteome analysis also indicated that RecA was significantly increased in the wild-type strain after MMS treatment and decreased afterwards. On the other hand, it was relatively rapidly and continually increased in the ada mutant strain after MMS treatment. These results indicate that the adaptive response is regulated partially by the SOS response, a complex, graded response to DNA damage that includes timely induction of gene products that block cell division and others that promote mutation, recombination and DNA repair. However, it has been reported that the adaptive response is distinct from previously characterized pathways of DNA repair, particularly from the SOS response [8, 33]. These findings indicated that the adaptation did not lead to expression of SOS functions, since the rec A and lex A mutant cells that were unable to perform SOS repair could be adapted to alkylating agents, such as MNNG [8, 33]. This is inconsistent with our result that showed high expression levels of genes involved in SOS response in the MMS-treated wild-type and ada mutant strains. Their expression levels in the ada mutant strain were the higher than the wild-type strain.
The up-regulated LexA regulon included DNA recombination and repair genes (rec AN and ruv AB), nucleotide excision repair genes (uvr ABD), the error-prone DNA polymerase genes (umu DC) and DNA polymerase II gene (pol B). Continued up-regulation of the LexA regulon suggests that blockage of DNA replication and/or DNA damage persists, leading to SOS signaling. These results indicate that SOS-induced levels of these gene products are needed for the adaptive response caused by MMS. In particular, other SOS-inducible gene products are required for efficient adaptive response in the absence of the ada gene to compensate for its role. For example, it was evident that DNA damage caused by MMS led to a significant induction of the dna NQ gene expression , suggesting a requirement for increased amounts of at least some DNA polymerase III holoenzyme subunits for recovery from the DNA damage caused by MMS. Our results are in agreement with the other findings and additionally show that enhanced amounts of at least some subunits of the DNA polymerase III holoenzyme (dna NT) might be necessary to repair DNA damage caused by MMS. The up-regulated DNA biosynthesis-related genes included the genes for chromosome replication (dna C) and DNA primase (dna G). However, these genes did not increase in MMS-treated wild-type cells. This result suggests that increased amounts of at least some subunits of DNA polymerase III holoenzyme are required for repair and recovery of MMS induced DNA damage, in agreement with the small number of polymerase molecules per cell.
Taken together, the increase in expression of these genes seems to be connected to the SOS response, and provides evidence that the adaptive response is a timely response that is tightly regulated in a coordinated fashion, through both positive and negative control by the SOS and other DNA repair systems. Interestingly, the adaptation of the ada mutant strain appears to occur within a narrow window in response to the level of SOS induction.
E. coli responds to alkylation stress by activating sets of co-regulated genes that help the cell to maintain homeostasis. Overall, the transcriptional and translational responses of the ada mutant strain by alkylation damage are similar to those of the wild-type strain, but some differences between the strains were observed within a narrow window following MMS treatment. The ada mutant strain showed that the adaptive response mediated a strong induction of many genes involved in DNA replication, recombination, modification and repair. This indicates that the adaptive response in the ada mutant strain by MMS treatment is a tightly regulated response that functions in a timely and coordinated fashion and is controlled both positively and negatively by the SOS and other DNA repair systems. Secondary effects of increased expression of drug or antibiotic resistance genes were observed with up-regulation of many transporter-related operons for acquiring MMS toxicity resistance. An additional interesting observation is that the ada mutation resulted in derepression of bacterial chemotaxis and flagellar synthesis, which suggests an additional role of Ada as a negative transcriptional regulator for the expression of the genes involved in chemotaxis and flagellar synthesis, although the Ada regulator might have only a limited influence on cellular physiology under normal growth condition.
E. coli W3110 (derived from K-12, λ-, F-, prototrophic) and its ada mutant (WA; W3110ada::Kmr) strains were used in this study. The mutant strain was constructed by disrupting the ada gene in the chromosome of E. coli W3110 by a homologous recombination system using λ Red recombinase .
Culture conditions and MMS treatment
Cells were cultivated at 37°C and 250 rpm in 100 mL of Luria-Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast extract, and 5 g/L NaCl) in 250-mL Erlenmeyer flasks. Cells grown for 15 h were diluted 1:100 in fresh LB medium and further cultured to an optical density at 600 nm (OD600) of 0.4. Methyl methanesulfonate (MMS; Sigma-Aldrich, St. Louis, MO, USA) was added to 0.04% v/v , and cells were collected at predetermined sampling times (0.5, 1.5 and 3.9 h) for the analyses of transcriptome and proteome. For comparison, both strains were also grown without MMS addition as controls. Cell growth was monitored by measuring the OD600 using a spectrophotometer (Ultraspec3000; Pharmacia Biotech, Uppsala, Sweden). When required, ampicillin (50 μg/mL) and/or kanamycin (35 μg/mL) were supplemented.
DNA microarray analysis
All procedures including RNA preparation, cDNA labeling, DNA hybridization and data analysis were carried out as described previously . GenePlorer TwinChip E. coli-6 K oligo chips (GT3001; Digital Genomics, Seoul, Korea) were used according to the manufacturer's protocol. The microarray images were obtained using the Axon Scanner (Axon, Inc., Union City, CA, USA), and analyzed using the GenePix 3.0 (Axon) and Genesis 1.5.0. beta 1 http://genome.tugraz.at softwares. Briefly, the signal intensities higher than the mean background intensities by 3-fold greater than the overall standard deviation were chosen. Global normalization was carried out by dividing each of fluorescence intensities by their sums. The expression level of each gene was normalized to the variance of 1. Duplicate replicates were carried out. DNA microarray data are available in Additional file 2. All DNA microarray data were also deposited in Gene Expression Omnibus (GEO) database (GSE16565).
Real-time PCR analysis
Real-time PCR analysis was performed as described previously  with the iCycler iQ real-time PCR detection system (Bio-Rad) using the iQ SYBR Green Supermix (Bio-Rad). The rrsB gene was used as a reference gene for normalization, and the data were analyzed using the 2-ΔΔCT method . The amplicons were obtained using the following primer sets.
alk A-for (5'-TGGCGAACGGCTGGATGATT-3')
alk A-rev (5'-TTCAACGGCATACCTAACGCTTT-3')
alk B-for (5'-GCCCATTGATCCGCAAAC-3')
alk B-rev (5'-CTGGAAATCTGGATAGCCCG-3')
aid B-for (5'-GAACGGCTGAATCCCTTGAACTG-3')
aid B-rev (5'-TGAAAACGCACATCG TCCAGAC-3')
Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis (2-DE) experiments were performed using the IPGphor IEF system (GE Healthcare Life Sciences, Chalfont St. Giles, UK) and Protean II xi Cell (Bio-Rad, Hercules, CA, USA) as described previously . Cell extracts were obtained as reported previously . The protein samples (200 μg) were applied to the Immobiline DryStrips (18 cm, pH 3-10 NL; GE Healthcare) using in-gel rehydration in an IPGphor (GE Healthcare) using five phases of stepped voltages from 200 to 8000 V with total focusing of 60 kV·h. The strips were then placed on 12% w/v SDS-PAGE gels prepared by the standard protocol . Protein spots were visualized using a silver staining kit (GE Healthcare) and the stained gels were scanned by a UMAX PowerLook 2100XL Scanner (UMAX Technologies, Inc., TX, USA). PDQuest 2-D Analysis Software (Bio-Rad) was used to automate the process of finding protein spots within the image and to quantify the density of the spots on a percentage of volume basis. Features resulting from non-protein sources (e.g. dust particles and scratches) were filtered out and protein spots were normalized and pairwise image comparisons were performed. At least triplicate gels of each sample were analyzed. All protein spots exhibiting at least 2-fold differences between the samples were evaluated for statistical significance using the Student's t-test and all spots with p values of < 0.05 were matched with the corresponding spots on the silver stained images for identification using LC-MS/MS.
LC-MS/MS and data analysis
For protein identification by the MS/MS analysis, samples were prepared as described previously . Tryptic peptides (10 μL aliquots) were analyzed by a nano-LC/MS system consisting of an Ultimate HPLC system (LC Packings, Amsterdam, Netherlands) and a quadrupole-time-of-flight (Q-TOF) MS (Micromass, Manchester, UK) equipped with a nano-ESI source as described previously . The MASCOT search server (version 1.8; http://www.matrixscience.com/) was used for the identification of protein spots by querying sequence of the trypsin digested peptide fragment data. Reference databases used for the identification of target proteins were UniProt Knowledgebase (Swiss-Prot and TrEMBL; http://kr.expasy.org/) and NCBI http://0-www.ncbi.nlm.nih.gov.brum.beds.ac.uk/.
This work was supported by the Korean Systems Biology Research Grant from the Ministry of Education, Science and Technology through the Korean Science and Engineering Foundation (M10309020000-03B5002-00000). Further supports by LG Chem Chair Professorship, IBM SUR program and Microsoft are appreciated.
- Sedgwick B: Nitrosated peptides and polyamines as endogenous mutagens in O6-alkylguanine-DNA alkyltransferase deficient cells. Carcinogenesis. 1997, 18: 1561-1567. 10.1093/carcin/18.8.1561.PubMedView ArticleGoogle Scholar
- Taverna P, Sedgwick B: Generation of an endogenous DNA-methylating agent by nitrosation in Escherichia coli. J Bacteriol. 1996, 178: 5105-5111.PubMed CentralPubMedGoogle Scholar
- Chaney SG, Sancar A: DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst. 1996, 88: 1346-1360. 10.1093/jnci/88.19.1346.PubMedView ArticleGoogle Scholar
- Hurley LH: DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer. 2002, 2: 188-200. 10.1038/nrc749.PubMedView ArticleGoogle Scholar
- Drabløs F, Feyzi E, Aas PA, Vaagbø CB, Kavli B, Bratlie MS, Peña-Diaz J, Otterlei M, Slupphaug G, Krokan HE: Alkylation damage in DNA and RNA--repair mechanisms and medical significance. DNA Repair. 2004, 3: 1389-1407. 10.1016/j.dnarep.2004.05.004.PubMedView ArticleGoogle Scholar
- Sedgwick B, Lindahl T: Recent progress on the Ada response for inducible repair of DNA alkylation damage. Oncogene. 2002, 21: 8886-8894. 10.1038/sj.onc.1205998.PubMedView ArticleGoogle Scholar
- Samson L, Cairns J: A new pathway for DNA repair in Escherichia coli. Nature. 1977, 267: 281-283. 10.1038/267281a0.PubMedView ArticleGoogle Scholar
- Jeggo P: Isolation and characterization of Escherichia coli K-12 mutants unable to induce the adaptive response to simple alkylating agents. J Bacteriol. 1979, 139: 783-791.PubMed CentralPubMedGoogle Scholar
- Lindahl T, Sedgwick B, Sekiguchi M, Nakabeppu Y: Regulation and expression of the adaptive response to alkylating agents. Annu Rev Biochem. 1988, 57: 133-157. 10.1146/annurev.bi.57.070188.001025.PubMedView ArticleGoogle Scholar
- Dinglay S, Trewick SC, Lindahl T, Sedgwick B: Defective processing of methylated single-stranded DNA by E. coli AlkB mutants. Genes Dev. 2000, 14: 2097-2105.PubMed CentralPubMedGoogle Scholar
- Jeggo P, Defais TM, Samson L, Schendel P: An adaptive response of E. coli to low levels of alkylating agent: comparison with previously characterised DNA repair pathways. Mol Gen Genet. 1977, 157: 1-9. 10.1007/BF00268680.PubMedView ArticleGoogle Scholar
- Lemotte PK, Walker GC: Induction and autoregulation of ada, a positively acting element regulating the response of Escherichia coli K-12 to methylating agents. J Bacteriol. 1985, 161: 888-895.PubMed CentralPubMedGoogle Scholar
- Nakabeppu Y, Sekiguchi M: Regulatory mechanisms for induction of synthesis of repair enzymes in response to alkylating agents: ada protein acts as a transcriptional regulator. Proc Natl Acad Sci USA. 1986, 83: 6297-301. 10.1073/pnas.83.17.6297.PubMed CentralPubMedView ArticleGoogle Scholar
- Takano K, Nakabeppu Y, Sekiguchi M: Functional sites of the Ada regulatory protein of Escherichia coli. Analysis by amino acid substitutions. J Mol Biol. 1988, 201: 261-271. 10.1016/0022-2836(88)90137-4.PubMedView ArticleGoogle Scholar
- Joyce AR, Palsson BØ: The model organism as a system: integrating 'omics' data sets. Nat Rev Mol Cell Biol. 2006, 7: 198-210. 10.1038/nrm1857.PubMedView ArticleGoogle Scholar
- Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, Goodlett DR, Aebersold R, Hood L: Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 2001, 292: 929-934. 10.1126/science.292.5518.929.PubMedView ArticleGoogle Scholar
- Yoon SH, Han MJ, Lee SY, Jeong KJ, Yoo JS: Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture. Biotechnol Bioeng. 2003, 81: 753-767. 10.1002/bit.10626.PubMedView ArticleGoogle Scholar
- Duy NV, Mäder U, Tran NP, Cavin JF, Tam LT, Albrecht D, Hecker M, Antelmann H: The proteome and transcriptome analysis of Bacillus subtilis in response to salicylic acid. Proteomics. 2007, 7: 698-710. 10.1002/pmic.200600706.PubMedView ArticleGoogle Scholar
- Nguyen VD, Wolf C, Mäder U, Lalk M, Langer P, Lindequist U, Hecker M, Antelmann H: Transcriptome and proteome analyses in response to 2-methylhydroquinone and 6-brom-2-vinyl-chroman-4-on reveal different degradation systems involved in the catabolism of aromatic compounds in Bacillus subtilis. Proteomics. 2007, 7: 1391-1408. 10.1002/pmic.200700008.PubMedView ArticleGoogle Scholar
- Landini P, Busby SJ: Expression of the Escherichia coli ada regulon in stationary phase: evidence for rpoS-dependent negative regulation of alkA transcription. J Bacteriol. 1999, 181: 6836-6839.PubMed CentralPubMedGoogle Scholar
- Landini P, Volkert MR: Regulatory responses of the adaptive response to alkylation damage: a simple regulon with complex regulatory features. J Bacteriol. 2000, 182: 6543-6549. 10.1128/JB.182.23.6543-6549.2000.PubMed CentralPubMedView ArticleGoogle Scholar
- Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997, 277: 1453-1469. 10.1126/science.277.5331.1453.PubMedView ArticleGoogle Scholar
- Hengge-Aronis R: Signal transduction and regulatory mechanisms involved in control of the σS (RpoS) subunit of RNA polymerase. Microbiol Mol Biol Rev. 2002, 66: 373-395. 10.1128/MMBR.66.3.373-395.2002.PubMed CentralPubMedView ArticleGoogle Scholar
- Neidhardt FC, Curtiss R, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Scharchter M, Umbarger HE: Escherichia coli and Salmonella: cellular and molecular biology. 1996, ASM Press, Washington DC., 2277-2294.Google Scholar
- Chilcott GS, Hughes KT: Coupling of flagellar gene expression to flagellar assembly in Salmonella enterica serovar typhimurium and Escherichia coli. Microbiol Mol Biol Rev. 2000, 64: 694-708. 10.1128/MMBR.64.4.694-708.2000.PubMed CentralPubMedView ArticleGoogle Scholar
- Ninfa EG, Stock A, Mowbray S, Stock J: Reconstitution of the bacterial chemotaxis signal transduction system from purified components. J Biol Chem. 1991, 266: 9764-9770.PubMedGoogle Scholar
- Laubacher ME, Ades SE: The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance. J Bacteriol. 2008, 190: 2065-2074. 10.1128/JB.01740-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Hirakawa H, Nishino K, Hirata T, Yamaguchi A: Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Bacteriol. 2003, 185: 1851-1856. 10.1128/JB.185.6.1851-1856.2003.PubMed CentralPubMedView ArticleGoogle Scholar
- Nishino K, Yamaguchi A: Overexpression of the response regulator evgA of the two-component signal transduction system modulates multidrug resistance conferred by multidrug resistance transporters. J Bacteriol. 2001, 183: 1455-145. 10.1128/JB.183.4.1455-1458.2001.PubMed CentralPubMedView ArticleGoogle Scholar
- Nishino K, Yamaguchi A: EvgA of the two-component signal transduction system modulates production of the yhiUV multidrug transporter in Escherichia coli. J Bacteriol. 2002, 184: 2319-2323. 10.1128/JB.184.8.2319-2323.2002.PubMed CentralPubMedView ArticleGoogle Scholar
- Rebeck GW, Samson L: Increased spontaneous mutation and alkylation sensitivity of Escherichia coli strains lacking the ogt O6-methylguanine DNA repair methyltransferase. J Bacteriol. 1991, 173: 2068-2076.PubMed CentralPubMedGoogle Scholar
- Sancar A: Structure and function of DNA photolyase. Biochemistry. 1994, 33: 2-9. 10.1021/bi00167a001.PubMedView ArticleGoogle Scholar
- Schendel PF, Defais M, Jeggo P, Samson L, Cairns J: Pathways of mutagenesis and repair in Escherichia coli exposed to low levels of simple alkylating agents. J Bacteriol. 1978, 135: 466-475.PubMed CentralPubMedGoogle Scholar
- Quiñones A, Kaasch J, Kaasch M, Messer W: Induction of dnaN and dnaQ gene expression in Escherichia coli by alkylation damage to DNA. EMBO J. 1989, 8: 587-593.PubMed CentralPubMedGoogle Scholar
- Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000, 97: 6640-6645. 10.1073/pnas.120163297.PubMed CentralPubMedView ArticleGoogle Scholar
- Baek JH, Lee SY: Novel gene members in the Pho regulon of Escherichia coli. FEMS Microbiol Lett. 2006, 264: 104-109. 10.1111/j.1574-6968.2006.00440.x.PubMedView ArticleGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.PubMedView ArticleGoogle Scholar
- Han MJ, Jeong KJ, Yoo JS, Lee SY: Engineering Escherichia coli for increased productivity of serine-rich proteins based on proteome profiling. Appl Environ Microbiol. 2003, 69: 5772-5781. 10.1128/AEM.69.10.5772-5781.2003.PubMed CentralPubMedView ArticleGoogle Scholar
- Lee JW, Lee SY, Song H, Yoo JS: The proteome of Mannheimia succiniciproducens, a capnophilic rumen bacterium. Proteomics. 2006, 6: 3550-3566. 10.1002/pmic.200500837.PubMedView ArticleGoogle Scholar
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685. 10.1038/227680a0.PubMedView ArticleGoogle Scholar
- Han M-J, Yoon SS, Lee SY: Proteome analysis of metabolically engineered Escherichia coli producing Poly(3-hydroxybutyrate). J Bacteriol. 2001, 183: 301-308. 10.1128/JB.183.1.301-308.2001.PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.